Compare the 10 manufacturers holding an active US Drug Master File for Difelikefalin API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
10 manufacturers hold an active Type II Drug Master File for DifelikefalinAPI, taken from the FDA's quarterly DMF list; 8 of them are listed in this directory. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| Cipla | India (Mumbai) | 37712 | 2023 |
| Chunghwa Chemical Synthesis & Biotech (CCSB) | Taiwan (New Taipei) | 38511 | 2023 |
| ALP Pharm Beijing | China (Beijing) | 38645 | 2023 |
| MSN Laboratories | India (Hyderabad) | 40537 | 2024 |
| Neuland Labs | India (Hyderabad) | 41503 | 2025 |
| Hybio Pharmaceutical | China | 42266 | 2025 |
| Sinopep Biopharma | China | 43858 | 2026 |
| Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd. | China | 44779 | 2026 |
Not yet listed in this directory, so we have not reviewed them. Names as printed in the FDA DMF list.
| DMF holder | US DMF | Filed |
|---|---|---|
| Wisdom Pharmaceutical Co Ltd | 41341 | 2025 |
| Suzhou Yifan Pharmaceutical Co Ltd | 43195 | 2025 |
Request API quotes from several manufacturers at once. Hold a Difelikefalin DMF and not listed? Add your company.